Glaxosmithkline Share News (GSK)

GSK and Theravance begin late-stage test for COPD treatment

GlaxoSmithKline has begun Phase III testing on a combined treatment for chronic obstructive pulmonary disease (COPD) with its US project partner Theravance. The global study is the first to evaluate the efficacy and safety of a triple combination of three drugs in 10,000 patients with COPD, all in

FX round-up: German and Portuguese concern weighs on euro

Continuing weaker data from Germany and banking concerns from Portugal saw the euro weaken against the dollar on Tuesday, as US central banking chief Janet Yellen was slightly more optimistic on the economy. Germany's ZEW index of investor and analyst expectations, which aims to predict economic de

UK MORNING BRIEFING: Meggitt Leads FTSE 100 On Takeover Speculation

GlaxoSmithKline, Theravance Initiate Phase III Of IMPACT Study

BUZZ-U.S. Stocks on the Move-Rockwood, La Jolla, Michael Kors

(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) U.S. s

GlaxoSmithKline recalls painkiller in Puerto Rico

July 14 (Reuters) - GlaxoSmithKline Plc recalled about 10,600 bottles of its painkiller sold in Puerto Rico after finding the packaging was not child-resistant as required by the Poison Prevention Packaging Act. Panadol is a paracetamol-based pain reliever which was sold exclusively in Pu

DIRECTOR DEALINGS: Glaxo Senior Executives Receive Shares

China charges investigators linked to GSK

Two foreign investigators linked to pharmaceutical giant GlaxoSmithKline (GSK) have been charged by prosecutors in Shanghai. Peter Humphrey, who was hired by GSK to find out who had been sending explicit videos of his China boss, and his wife, have been charged with "illegally obtaining private inf

UPDATE 3-China charges GSK-linked investigators for illegally obtaining private information

* China case against GSK-linked investigator couple lodged with court * Couple alleged to have illegally obtained private information * Humphrey apologises for breaking any Chinese law - state TV * Trial to begin behind closed doors on Aug. 7 - family friends (Adds comment fro

UK MIDDAY BRIEFING: Sports Direct Heads To Australasia With MySale

TOP NEWS: Shire "Willing To Recommend" Raised AbbVie Offer

Monday broker round-up UPDATE

Abcam: Numis cuts target price from 510p to 490p and stays with its add rating. ARM Holdings: Credit Suisse reduces target price from 1200p to 1125p and maintains an outperform rating. AstraZeneca: Jefferies reduces target price from 4850p to 4790p maintaining a hold recommendation. BP: Credit Su

UPDATE: PRESS: Glaxo Investigator And Wife Formally Charged - Xinhua

UK BROKER RATINGS: HSBC Cuts Easyjet Price Target By 22%

Glaxo Linked Investigators Indicted In China For Illegal Investigation